Clinical Trials Browser

Phase 1/2 × Pancrelipase × 90 days × Clear all

NCT05642962 2026-02-25

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 1/2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms